← Open Payments lookup

STACEY MEEK: Open Payments

NPI 1669108791 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$465 in 17 payments from 10 companies in 2025. Trend: 2023 $198 · 2024 $160 · 2025 $465

Food & beverage: $465
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$166
E.R. Squibb & Sons, L.L.C.3$72
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$45
Indivior Inc.2$44
Teva Pharmaceuticals USA, Inc.2$41
Axsome Therapeutics, Inc.1$26
AstraZeneca Pharmaceuticals LP1$20
Alkermes, Inc.1$18
ABBVIE INC.1$17
Vanda Pharmaceuticals Inc.1$17

Products named: ABILIFY MAINTENA, COBENFY, CAPLYTA, SUBLOCADE, AUSTEDO XR, ABILIFY ASIMTUFII, Auvelity, AIRSUPRA.

Industry payments across DE — which companies pay providers there.